759–6 Computerization of the ACC/AHA Guidelines for PTCA and CABG - Use of a Relational Database for Comparison with RAND Expert Panel Ratings and University of Maryland Revascularization Appropriateness Scores (RAS)  by Lauer, Michael A. et al.
Conclusions: This first report of neural networks for the diagnosis of
myocardial infarction embedded within a deterministic logic program has
shown that (11 the technique significantly improves the diagnosis of inferior
though not anterior MI; 12) the evaluation of specificity using only normals is
misleading; (3) the technique can usefully be adopted selectively to enhance
diagnostic ECG programs in future.
5e = sensitivity, Sp = specificity, N = normal. L = LVH. 0 = overall
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can be of any ordered form, including binary, categoric, integer, or contin-
uous. The network can categorize data into two or more classes, and also
produces a degree of membership for each class. Time series data, such as
electrocardiograms, are important measurements for many diagnoses. An
ECG may have an overall interpretation which can be used in the rule-based
component, or categorized to be used in the neural network component.
However, other analyses may also prove useful. In the application shown,
a measure of variability for 24-hour Holter tapes is used. The combination
of these techniques is illustration in a decision support system for the di-
agnosis and treatment of heart disease, including the use of a rule base, a
supplementary neural network model of exercise testing data (ED). and a
time series analysis for Holter data.
2:301759-31 Prediction Models for Outcome of Coronary Surgery
and Coronary Angioplasty on a Desktop
Willia m S. Weintra ub. Emory University Sch ofMedicine. Atlanta. GA
There is a need in clinical practice for rapid accessibility of outcome data
in rapid fashion for clinical decision making. Data for this purpose come
largely from clinical trials and databases. Emory University has a cardiovas-
cular database with 80,000 patients which includes all cardiovascular surgi-
cal procedures and interventional procedures in the coronaries since 1972.
Querying the database to examine outcome is practical for research, but lim-
ited as a clinical tool. Thus, the data in the database are largely accessible
through published datasets and prediction models. These prediction mod-
els have been reflected in a computer program that may run on a personal
computer. In hospital outcomes are predicted by stepwise logistic regres-
sion and long term outcome (time-ta-eventl by Cox model analysis. Mean
survival curves for the Cox model are needed as well as the coefficients.
The data for survival curves is stored in an Access 2.0 database. The pri-
mary application is programmed in Visual Basic 3.0 and will run on any IBM
PC or clone running DOS 5.0 or higher and Windows 3.0 or higher. The ap-
plication uses a full graphical user interface. The in-hospital outcome data
are expressed as percentages. Survival (time-to-event) data are expressed
as survival curves. The entire application is mouse controlled and there is no
typing at any time. The user starts the program from a windows icon and
then a main menu offers a selection of models. The user clicks on a model.
Then a specific screen for the model appears and the user selects values
for the correlates of the endpoint. When done the user clicks for the data to
be displayed. Movement within models and between models is straight for-
ward, simple and fast. The current models after coronary surgery: in hospital
death, Q wave myocardial infarction, stroke, death after reoperative surgery,
long term survival, non-fatal events and survival after reoperative ·surgery.
The current models after angioplasty: in hospital death, Q wave myocardial
infarction, emergency surgery, restenosis, long term survival and long term
cardiac events. Clinical cardiologists and cardiology fellows can learn to use
the program essentially immediately, without training. Clinical understanding
and proper use of the tool are the limitation as the computer application has
been simplified as much as possible.
2:451759-41 Information Integration for Cardiology Decision
Support
D.L. Hudson, M.E. Cohen, P.e. Deedwanla. University of Ca!Jfornia, San Francisco;
California State University. Fresno; VA Medical Center, Fresno
Electronic medical records pose a challenge because of the complex types
of data which are included. Decision support systems must be able to deal
effectively with these data types. In the expert system demonstrated here, a
diversity of data types are included. These data are processed by three differ-
ent methods. However, the different methods of processing are transparent
to the user. An overall rule-based interface integrates the different methods
into one comprehensive system. Data types include crisp data, fuzzy data,
temporal data, and numerical representation of chaotic analysis. Some data
items which appear to be crisp, for example, test results, are more accu-
rately represented as fuzzy numbers which indicate the degree of precision
of the test. Four types of temporal data are considered: change in value
from previous value, change in value relative to a specified time interval, du-
ration data, and sequence data. A measure developed by the authors which
determines the degree of variability in time series data is also included. The
knowledge-based portion of the system utilizes approximate reasoning tech-
niques which allows weighting of antecedents and partial presence of symp-
toms. The rule base is used as the interface which invokes a neural network
model or time series analysis if certain rules are substantiated. The neural
network model is a three-level feed-forward model based on a non-statistical
learning supervised learning algorithm developed by the authors. Input data
3:001759-51 Use of an Interactive Electronic Whiteboard to Teach
Clinical Cardiology Decision Analysis to Medical
Students
John F. Murphy, Nilesh L. Jain, S. Andrew Spooner, Scott W Hassan, John
L. Schnase, Edward S. Metcalfe, Paul A. Schoening, Edward L. Cunnius, Mark
E. Frisse. Washington University School ofMedicine, St. Louis, MO
We used innovative state-of-the-art computer and collaboration technolo-
gies to teach first-year medical students an analytic methodology to solve
difficult clinical cardiology problems to make informed medical decisions.
Clinical examples included the decision to administer thrombolytic therapy
considering the risk of hemorrhagic stroke, and activity recommendations
for athletes at risk for sudden death. Students received instruction on the
decision-analytic approach which integrates pathophysiology, treatment ef-
ficacy, diagnostic test interpretation, health outcomes, patient preferences,
and cost-effectiveness into a decision-analytic model.
The traditional environment of a small group and blackboard was signifi-
cantly enhanced by using an electronic whiteboard, the Xerox LiveBoard '•.
The LiveBoard features an 80486-based personal computer, large (3' x 4')
display, and wireless pens for input. It allowed the integration of decision-
analytic software, statistical software, digital slides, and additional media.
We developed TIDAL (Team Interactive Decision Analysis in the Large-screen
environment), a software package to interactively construct decision trees,
calculate expected utilities, and perform one- and two-way sensitivity analy-
ses using pen and gesture inputs. The Live Board also allowed the novel in-
corporation of Gambler, a utility assessment program obtained from the New
England Medical Center. Gambler was used to obtain utilities for outcomes
such as non-disabling hemorrhagic stroke. The interactive nature of the Live-
Board allowed real-time decision model development by the class, followed
by instantaneous calculation of expected utilities and sensitivity analyses.
The multimedia aspect and interactivity were conducive to extensive class
participation.
Ten out of eleven students wanted decision-analytic software available for
use during their clinical years and all students would recommend the course
to next year's students. We plan to experiment with the electronic collabora-
tion features of this technology and allow groups separated by time or space
to collaborate on decisions and explore the models created.
3:15
Computerization of the ACC/AHA Guidelines for
PTCA and CABG - Use of a Relational Database for
Comparison with RAND Expert Panel Ratings and
University of Maryland Revascularization
Appropriateness Scores (RAS)
Michael A. Lauer, Andrew A. Ziskind, Cynthia C. Lemmon, Robert A. Vogel.
University ofMaryland, Baltimore, Maryland
With the increased emphasis on determining the need for coronary revascu-
larization, appropriateness scoring systems have been developed. We devel-
oped software to apply clinically the complex ACC/AHA Guidelines for PTCA
(1993) and CABG (19911
Using 40 on an Apple Macintosh, we designed a relational patient
database which captures key clinical information: patient demographics,
clinical presentation, medications, comorbidity, exercise test results, left
ventricular function, angiographic data, and followup events. Compiled code
automatically assigns the patient to the proper clinical subsection, interprets
relevant coronary anatomy and calculates the appropriateness classification
- Class I (general agreement with indication), Class II (divergence of opin-
ion), and Class III (general agreementthat procedure is not indicated). In addi-
tion to providing objective appropriateness scores using the ACC/AHA PTCA
and CABG Guidelines, the system automatically compares those scores with
RAND Expert Panel Ratings and the University of Maryland RAS.
Reports can be produced based on specified search criteria for an individ-
ual patient or an entire patient group, thus allowing analysis of patterns of
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binary restenosis
rate(%)
O( 0%)
5(12%)
3
reference MLD stenosis
diameter (mm) (mm) (%)
pre procedure 294 ± 0.37 094 ± 0.28 68.7 ± 9.9
pre-dilatation 2.91 ± 0.36 159 ± 032 45.9 ± 13.5
post stenting 2.89 ± 0.39 269 ± 0.22 59 ± 10.8
next day In ~ 36) 2.88 ± 032 2.64 ± 0.21 8.0± 8.0
1mo FlU (n = 35) 291 ± 0.35 2.57 ± 023 11.2± 8.7
3moF/U(n = 41) 2.84 ± 0.32 2.02 ± 0.52 28.9 ± 17.3
6 mo FlU (n = 15) 2.84 ± 0.32 1.82 ± 0.56 36.6 ± 18.2
Complications
Repeat angioplasty was required in 4 of 8 patients with restenosis. Thus,
the Cordis stent implantation can be achieved with a high degree of technical
and clinical success because of its flexible design and good visibility. Further-
more, its very low complication rates are encouraging. Restenosis rate at 3
months follow-up period is acceptably low.
acutelsubacute occlusion: 0 OInon Q-MI: 1 12%) CABG: 0
death: 0 groin hematoma: 2 (4%) blood transfusions: 3 (5%)
Angiographic findings lesion length: g.O ± 5.4 mm
In order to assess the safety and efficacy of Wiktor Stent (WS) implantation,
data from the French WS registry were reviewed. Between February 1991
and April 1994, 245 stent placements were attempted in 225 patients for
acute or threatening vessel closure after PTCA in 119 (52.9%), nonocclusive
dissection in 11 (4.9%), suboptimal dilatation in 30 (13.3%), restenosis in 55
(24.5%) and de novo lesions in 10 (4.4%). Implanted site was LAD in 34.7%,
RCA in 40.9%, left Circumflex in 16%, left main in 1.3% and saphenous graft
in 7.1 %. Stent placement was successful in 93.8% of patients (pts). Failure
was due to peripheral stent migration in 2 pts, inability to cross the lesion
in 8, non-target placement in one and acute occlusion in 3 others. Ten pts
(4.4%) underwent emergent CABG. Death occurred in 5 pts (2.2%) and was
due to cardiac complications in 3 and intracerebral hemorrhage in 2. Sub-
acute thrombosis occurred in 9 pts (4%). Clinical success rate (procedural
success without in hospital death, CABG or MI) was 86.2%. Vascular com-
plications occurred in 4 pts (1.8%). To date. coronary angiography has been
performed in 120/172 (69.8%) eligible pts and showed restenosis (>50%
stenosis) in 26.7%. Factors associated with restenosis were male gender,
current smoking and site of implantation.
Conclusion: WS implantation is very efficacious in reversing critical situa-
tions after angioplasty while carrying an acceptable risk.
Clinical Experience with Medtronic Wiktor Stent
Implantation: A Report from the French
Multicentric Registry
Elie K. Karouny, Khalife Khalife, Jean-Pierre Monassier, Bernard Lancelin,
Gilles Grollier, Didier Carrie, Bernard Assoun, Michel Jean, Jacques Pue!.
Cardiologie Purpan, Toulouse, France
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care. The system can also be accessed remotely via modem to permit its
use as a revascularization "consultant."
Conclusion: This program automatically and objectively determines
ACC/AHA, RAND and RAS revascularization appropriateness ratings. It is a
useful tool for evaluating appropriateness of PTCA or CABG in individual pa-
tients as well as for analyzing patterns of care.
The results of Balloon expandable Micro Stent'" (Applied Vascular Engineer-
ing Canada, Inc) were analyzed. This stent is unique in that it comes pre-
mounted on a balloon in non articulated multiples of 4 mm units. The stent is
available in 4, 8 and 12 mm lengths. The short stent unit length allows it to be
used in short lesions, tortuous anatomy, and for complex situations such as
stent delivery through a deployed stent. 16 lesions in 15 patients (pts) were
treated with Micro stent. A one unit (4 mm) stent was used in 3 lesions, a 2
unit (8 mm) stent in 3 lesions and a 3 unit stent (12 mm) stent in 8 lesions re-
spectively. Indication for stent implantation was elective in 15 lesions and for
acute closure after balloon angioplasty in 1 lesion. Vessel distribution was 8
LCX (50%). 5 RCA (31 %) and 3 LAD (19%). In 8 lesions (50%) other types of
stents (Palmaz-Schatz, Gianturco-Roubin orWiktor stent} were deployed. The
reason for the selection of Micro Stent was failed stent delivery using other
type of stents in 9 (56%). tortuous vessel in 4 lesions and for 3 short lesions.
Stent deployment in 8 (50%) lesions were performed through a previously
deployed stent. There was 1 delivery failure due to a failure to pre dilate the
lesion. Intracoronary ultrasound was performed to confirm the optimal stent
expansion and position. Stent migration was noted in 3 lesions. When stent
expansion was optimized, pts received no anticoagulation and either aspirin
325 mglday or Ticlopidine 500 mglday for 1 month with aspirin 325 mg for
5 days. 13 patients (87%) were treated without anticoagulation after stent
deployment. Ouantitative angiographic (AG) measurements is shown in the
table below:
Preliminary Experience of Coronary Stenting with
the Micro Stent™
Antonio Colombo, Luigi Maiello, Shigeru Nakamura, Patrick Hall,
Simonetta Blengino, Leo Finci, Giovanni Martini. Columbus Hospital, Milan, Italy
There was no stent thrombosis at 1 month follow up.
Conclusions. (1) The Micro stent showed high trackability despite complex
anatomy or delivery failure with other types of stents. (2) Stent delivery to dis-
tal lesions through a deployed stent was successful in all cases. (3) When
optimal Micro stent expansion is achieved. antiplatelet therapy (without anti-
coagulation) is effective in preventing stent thrombosis despite use in small
vessels.
Naoya Hamasaki, Hideyuki Nosaka, Masakiyo Nobuyoshl. Kokura Memorial
Hospital, f(jtakyushu, Japan
To assess the safety and efficacy of the Cordis stent, implantation was at-
tempted in 63 consecutive patients and 64 lesions from Jan. to Aug. 1994
(mean age: 63 years, % male: 79%, % previous MI: 62%, % multi vessel
disease: 47%). The balloon expandable Cordis stent was made up of a sin-
gle strand, very flexible, radiopaque continuous tantalum wire, and was 3.0
or 3.5 mm in diameter and 18 mm in length. The Cordis stent was implanted
electively in 44 lesions (69%), thirty-four of the 64 (58%) were restenotic le-
sions. Locations of the stented artery were LMT in 1, LAD in 28, LCX in 10
and RCA in 25 lesions (single stealing: 51. multiple stenting: 13,3.0 mm
stent: 39, 3.5 mm stent: 25). Unfavorable angiographic morphology (eccen-
tricity, dissection. calcification. ulceration or bend > 45') was noted in 43
lesions (67%). Delivery success was achieved in 57 lesions (90%). Rescue
stenting with this stent after the placement of a different stent had failed
was successful in 3 lesions. Complications and angiographic findings are as
follows.
AntOniO Colombo, Shigeru Nakamura, Patrick Hall, Luigi Maiello, Leo Finei,
Giovanni Martini. Columbus Hospital, Milan, Italy
The Wiktor coronary stent has been implanted in 82 lesions in 68 patients.
The indication for stent implantation was 49 elective (57%), 10 threatened
closure (12%), 9 SUboptimal PTCA (11 %), 7 chronic total occlusion (9%), 4
restenosis (5%), and 3 acute occlusion (4%). Vessel distribution was 39 RCA
(48%), 31 LAD (37%) and 12 LCX (15%). Successful stent implantation was
achieved in 77 lesions (94%). Average Wiktor stent per lesion was 1.4 ±
0.8 (range 1 to 4). More than one stent was used in 53 patients (69%). Le-
sion length was 14.8 ± 9.7 mm. Final balloon/vessel ratio was 1.03 ± 0.15.
Maximum inflation pressure was 16 ± 3 atmospheres. There were 5 lesions
that required an additional Palmaz-Schatz stent inside the Wiktor to reinforce
the lumen support. Mild stent structural deformity (expanded strut gap) was
seen in 8 lesions. There were 5 stents with severe stent deformity due to
shrinkage (n = 3) or uncoiling (n = 2). 59 patients (93%) with 72 lesions
(88%) of were treated with only antiplatelet therapy after stent implantation
with intravascular ultrasound guidance. There were 2 CABG due to stent se-
vere stent deformity. One death was due to femoral artery occlusion with
multiple organ failure. To date, 35 of an eligible 59 lesions (59%) received
4-6 months angiographic follow up (F/U)
A Prospective Study of Wiktor Coronary Stent
Implantation without Anticoagulation
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There was one stent thrombosis that occurred 8 days after the stent proce-
dure and 5 days after antiplatelet therapy was inadvertently stopped. Wiktor
stent restenosis by ::::50% diameter stenosis was present in 8 patients (23%).
